YY1 restrained cell senescence through repressing the transcription of p16

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 1876-1883

  Wang, Xiuli ^a   Feng, Yunpeng ^a   Xu, Liang ^a   Chen, Yuli ^a   Zhang, Yu ^a   Su, Dongmei ^a   Ren, Guoling ^a   Lu, Jun ^a   Huang, Baiqu ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Cell senescence; HDAC3; HDAC4; p16; YY1

Indexed keywords

BETA GALACTOSIDASE; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HISTONE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; TRANSCRIPTION FACTOR YY1;

ACETYLATION; ARTICLE; CELL AGING; CELL ENLARGEMENT; CELL STRUCTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE ACTIVITY; GENETIC EPIGENESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ACETYLATION; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; YY1 TRANSCRIPTION FACTOR;

EID: 50849120018     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.05.015     Document Type: Article

References (39)

1. Austen M., Luscher B., and Luscher-Firzlaff J.M. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J. Biol. Chem. 272 (1997) 1709-1717
2. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389 (1997) 349-352
3. Thomas M.J., and Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?. Gene 236 (1999) 197-208
4. Lee T.C., Zhang Y., and Schwartz R.J. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis. Oncogene 9 (1994) 1047-1052
5. Lewis B.A., Tullis G., Seto E., Horikoshi N., Weinmann R., and Shenk T. Adenovirus E1A proteins interact with the cellular YY1 transcription factor. J. Virol. 69 (1995) 1628-1636
6. Shrivastava A., and Calame K. An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. Nucleic Acids Res. 22 (1994) 5151-5155
7. Ye J., Cippitelli M., Dorman L., Ortaldo J.R., and Young H.A. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol. Cell. Biol. 16 (1996) 4744-4753
8. Seto E., Lewis B., and Shenk T. Interaction between transcription factors Sp1 and YY1. Nature 365 (1993) 462-464
9. Shrivastava A., Saleque S., Kalpana G.V., Artandi S., Goff S.P., and Calame K. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262 (1993) 1889-1892
10. Bauknecht T., See R.H., and Shi Y. A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J. Virol 70 (1996) 7695-7705
11. Liu Q., Merkler K.A., Zhang X., and McLean M.P. Prostaglandin F2alpha suppresses rat steroidogenic acute regulatory protein expression via induction of Yin Yang 1 protein and recruitment of histone deacetylase 1 protein. Endocrinology 148 (2007) 5209-5219
12. Luke M.P., Sui G., Liu H., and Shi Y. Yin Yang 1 physically interacts with Hoxa11 and represses Hoxa11-dependent transcription. J. Biol. Chem. 281 (2006) 33226-33232
13. Yao Y.L., and Yang W.M. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J. Biol. Chem. 278 (2003) 42560-42568
14. Cress W.D., and Seto E. Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184 (2000) 1-16
15. Han S., Lu J., Zhang Y., Cheng C., Han L., Wang X., Li L., Liu C., and Huang B. Recruitment of histone deacetylase 4 by transcription factors represses interleukin-5 transcription. Biochem. J. 400 (2006) 439-448
16. Mokrani H., Sharaf el Dein O., Mansuroglu Z., and Bonnefoy E. Binding of YY1 to the proximal region of the murine beta interferon promoter is essential to allow CBP recruitment and K8H4/K14H3 acetylation on the promoter region after virus infection. Mol. Cell. Biol. 26 (2006) 8551-8561
17. Aalfs J.D., and Kingston R.E. What does chromatin remodeling mean?. Trends. Biochem. Sci. 25 (2000) 548-555
18. Lomonte P., Thomas J., Texier P., Caron C., Khochbin S., and Epstein A.L. Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1. J. Virol. 78 (2004) 6744-6757
19. Barnes P.J., Adcock I.M., and Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur. Respir. J. 25 (2005) 552-563
20. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
21. Ohtani N., Zebedee Z., Huot T.J., Stinson J.A., Sugimoto M., Ohashi Y., Sharrocks A.D., Peters G., and Hara E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409 (2001) 1067-1070
22. Bracken A.P., Kleine-Kohlbrecher D., Dietrich N., Pasini D., Gargiulo G., Beekman C., Theilgaard-Monch K., Minucci S., Porse B.T., Marine J.C., Hansen K.H., and Helin K. The polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21 (2007) 525-530
23. Seligson D., Horvath S., Huerta-Yepez S., Hanna S., Garban H., Roberts A., Shi T., Liu X., Chia D., Goodglick L., and Bonavida B. Expression of transcription factor Yin Yang 1 in prostate cancer. Int. J. Oncol. 27 (2005) 131-141
24. Lu J., Sun H., Wang X., Liu C., Xu X., Li F., and Huang B. Interleukin-12 p40 promoter activity is regulated by the reversible acetylation mediated by HDAC1 and p300. Cytokine 31 (2005) 46-51
25. Kondo Y., Shen L., and Issa J.P. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell. Biol. 23 (2003) 206-215
26. Sui G., Affar el B., Shi Y., Brignone C., Wall N.R., Yin P., Donohoe M., Luke M.P., Calvo D., Grossman S.R., and Shi Y. Yin Yang 1 is a negative regulator of p53. Cell 117 (2004) 859-872
27. Huang W., Tan D., Wang X., Han S., Tan J., Zhao Y., Lu J., and Huang B. Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1. Biochem. Biophys. Res. Commun. 339 (2006) 165-171
28. Xu H.J., Zhou Y., Ji W., Perng G.S., Kruzelock R., Kong C.T., Bast R.C., Mills G.B., Li J., and Hu S.X. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15 (1997) 2589-2596
29. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., and Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9363-9367
30. Wang X., Pan L., Feng Y., Wang Y., Han Q., Han L., Han S., Guo J., Huang B., and Lu J. p300 plays a role in p16(INK4a) expression and cell cycle arrest. Oncogene 27 (2008) 1894-1904
31. Pellizzaro C., Coradini D., Daniotti A., Abolafio G., and Daidone M.G. Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines. Int. J. Cancer 91 (2001) 654-657
32. Gordon S., Akopyan G., Garban H., and Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25 (2006) 1125-1142
33. Baritaki S., Huerta-Yepez S., Sakai T., Spandidos D.A., and Bonavida B. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1. Mol. Cancer Ther. 6 (2007) 1387-1399
34. Baritaki S., Katsman A., Chatterjee D., Yeung K.C., Spandidos D.A., and Bonavida B. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J. Immunol. 179 (2007) 5441-5453
35. Affar el B., Gay F., Shi Y., Liu H., Huarte M., Wu S., Collins T., Li E., and Shi Y. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol. Cell. Biol. 26 (2006) 3565-3581
36. Basu A., Park K., Atchison M.L., Carter R.S., and Avadhani N.G. Identification of a transcriptional initiator element in the cytochrome c oxidase subunit Vb promoter which binds to transcription factors NF-E1 (YY-1, delta) and Sp1. J. Biol. Chem. 268 (1993) 4188-4196
37. Becker K.G., Jedlicka P., Templeton N.S., Liotta L., and Ozato K. Characterization of hUCRBP (YY1, NF-E1, delta): a transcription factor that binds the regulatory regions of many viral and cellular genes. Gene 150 (1994) 259-266
38. Shi Y., Lee J.S., and Galvin K.M. Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332 (1997) 49-66
39. Shi W., Hoeflich A., Flaswinkel H., Stojkovic M., Wolf E., and Zakhartchenko V. Induction of a senescent-like phenotype does not confer the ability of bovine immortal cells to support the development of nuclear transfer embryos. Biol. Reprod. 69 (2003) 301-309